EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0J4V: Heron Therapeutics INC

12 Nov 2025
LAST:

1.110

CHANGE:
 0.02		OPEN:
1.140		HIGH:
1.145		ASK:
0.000		VOLUME:
21.6K
CHG(%):
1.77		PREV:
1.130		LOW:
1.102		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 251.1401.1451.1021.11021.6K
11 Nov 251.0901.1301.0901.13050.7K
10 Nov 251.1051.1101.1001.110412
07 Nov 251.0621.0901.0601.09031.2K
06 Nov 251.0801.1001.0801.08222.1K
05 Nov 251.1101.1401.0701.13016.2K
04 Nov 251.3301.3301.0001.10047.6K
03 Nov 251.1681.1701.0951.1052.2K
31 Oct 251.1451.1901.1451.17010.2K
30 Oct 251.1401.1801.1401.16014.8K

COMPANY PROFILE

Name:Heron Therapeutics INC
About:Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
Address:100 Regency Forest Drive, Cary, NC, United States, 27518
Website:https://www.herontx.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.01 
PEG Ratio:0.00 
Price to Sales:0.59 
Price to Book:0.19 
Profit Margin:-0.01 
Operating Margin:-0.04 
Return on Assets:0.00 
Return on Equity:0.22 
EPS Ratio:-2.29 
Revenue:149.69M 
EBITDA:3.56M 
Shares:78.02M 
Market Cap:86.6M 

TECHNICAL INDICATORS

MA5:1.100.5%
MA10:1.120.8%
MA20:1.186.5%
MA50:1.2412.0%
MA100:1.5035.2%
MA200:1.7860.0%
STO9:11.29 
STO14:11.29 
RSI14:41.07
WPR14:-79.71
MTM14:-0.11
ROC14:-0.09 
ATR:0.06 
Week High:1.153.2%
Week Low:1.064.7%
Month High:1.3723.5%
Month Low:1.0060.0%
Year High:2.66139.6%
Year Low:1.0011.0%
Volatility:26.96 

RECENT SPLITS

Date Ratio
10 Oct 20221-25
11 Jun 20181-10

RECENT DIVIDENDS

Date Amount
15 Mar 2022$7.13